Literature DB >> 32288728

Glucocorticoids in the treatment of acute respiratory distress syndrome.

F Roche-Campo1, H Aguirre-Bermeo1, J Mancebo1.   

Abstract

Acute respiratory distress syndrome (ARDS) is characterized by local inflammation and an intense systemic inflammatory reaction. Glucocorticoid administration has been suggested due to their anti-inflammatory properties. However, results from the initial studies of glucocorticoids in ARDS, which evaluated high-dose and short-term treatments, were negative. More recent studies have evaluated the effect of lower doses of glucocorticoids administered over longer periods, but the results thus far have been inconclusive. © Société de réanimation de langue française (SRLF) and Springer-Verlag France 2011.

Entities:  

Keywords:  Acute respiratory distress syndrome; Glucocorticoids; Treatment

Year:  2011        PMID： 32288728      PMCID： PMC7117829          DOI： 10.1007/s13546-011-0316-1

Source DB:  PubMed          Journal:  Reanimation        ISSN： 1624-0693


  82 in total

Review 1.  Randomized trials stopped early for benefit: a systematic review.

Authors:  Victor M Montori; P J Devereaux; Neill K J Adhikari; Karen E A Burns; Christoph H Eggert; Matthias Briel; Christina Lacchetti; Teresa W Leung; Elizabeth Darling; Dianne M Bryant; Heiner C Bucher; Holger J Schünemann; Maureen O Meade; Deborah J Cook; Patricia J Erwin; Amit Sood; Richa Sood; Benjamin Lo; Carly A Thompson; Qi Zhou; Edward Mills; Gordon H Guyatt
Journal:  JAMA       Date:  2005-11-02       Impact factor: 56.272

2.  High-dose corticosteroids in patients with the adult respiratory distress syndrome.

Authors:  G R Bernard; J M Luce; C L Sprung; J E Rinaldo; R M Tate; W J Sibbald; K Kariman; S Higgins; R Bradley; C A Metz
Journal:  N Engl J Med       Date:  1987-12-17       Impact factor: 91.245

3.  Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial.

Authors:  Alain Mercat; Jean-Christophe M Richard; Bruno Vielle; Samir Jaber; David Osman; Jean-Luc Diehl; Jean-Yves Lefrant; Gwenaël Prat; Jack Richecoeur; Ania Nieszkowska; Claude Gervais; Jérôme Baudot; Lila Bouadma; Laurent Brochard
Journal:  JAMA       Date:  2008-02-13       Impact factor: 56.272

4.  Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis.

Authors: 
Journal:  N Engl J Med       Date:  1987-09-10       Impact factor: 91.245

5.  Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine.

Authors:  Paul E Marik; Stephen M Pastores; Djillali Annane; G Umberto Meduri; Charles L Sprung; Wiebke Arlt; Didier Keh; Josef Briegel; Albertus Beishuizen; Ioanna Dimopoulou; Stylianos Tsagarakis; Mervyn Singer; George P Chrousos; Gary Zaloga; Faran Bokhari; Michael Vogeser
Journal:  Crit Care Med       Date:  2008-06       Impact factor: 7.598

6.  Do glucocorticoids decrease mortality in acute respiratory distress syndrome? A meta-analysis.

Authors:  Ritesh Agarwal; Alok Nath; Ashutosh N Aggarwal; Dheeraj Gupta
Journal:  Respirology       Date:  2007-07       Impact factor: 6.424

7.  Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment.

Authors:  G U Meduri; E A Tolley; A Chinn; F Stentz; A Postlethwaite
Journal:  Am J Respir Crit Care Med       Date:  1998-11       Impact factor: 21.405

8.  Hydrocortisone therapy for patients with septic shock.

Authors:  Charles L Sprung; Djillali Annane; Didier Keh; Rui Moreno; Mervyn Singer; Klaus Freivogel; Yoram G Weiss; Julie Benbenishty; Armin Kalenka; Helmuth Forst; Pierre-Francois Laterre; Konrad Reinhart; Brian H Cuthbertson; Didier Payen; Josef Briegel
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

9.  Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial.

Authors:  G U Meduri; A S Headley; E Golden; S J Carson; R A Umberger; T Kelso; E A Tolley
Journal:  JAMA       Date:  1998-07-08       Impact factor: 56.272

10.  Steroid treatment for persistent ARDS: a word of caution.

Authors:  B Taylor Thompson; Marek Ancukiewicz; Leonard D Hudson; Kenneth P Steinberg; Gordon R Bernard
Journal:  Crit Care       Date:  2007       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.